V
ViOptix
ViOptix, a biotech company, manufactures innovative proprietary products for tissue oximetry–measuring oxygen saturation levels in tissues
About ViOptix
ViOptix operates in the medical technology sector, specializing in real-time measurement of oxygen saturation, a critical indicator of tissue health. The company serves healthcare professionals, particularly surgeons, by providing advanced tools that enhance clinical confidence and surgical outcomes. ViOptix's primary product, the T.Ox, offers anytime, anywhere access to vital information, ensuring better decision-making during surgeries. The business model revolves around selling these high-tech devices to hospitals and medical institutions, generating revenue through direct sales and ongoing customer support. Recognized for innovation, ViOptix has received accolades such as the New Product Innovations Award by Frost & Sullivan. The company is committed to improving surgical standards and has demonstrated efficacy through numerous clinical studies.
Source: Dealroom company dataAt a glance
- Founded
- 1999
- Headquarters
- Newark, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
- MCMDS Capital
Morningside
Vivo Capital
Thrivent Investment Management- CPChannel Medical Partners
- LILincoln Funds International
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ViOptix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ViOptix on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.